Considering the frequent expression of CD70 in various tumors beyond melanoma and renal cell carcinoma, such as nasopharyngeal carcinoma, mesothelioma, and glioblastoma, the predictive value of sCD27 may hold promise for broader application across various cancer types. This evidence concerns the gene CD70 and mesothelioma.